Detalhe da pesquisa
1.
Identification of an epilepsy-linked gut microbiota signature in a pediatric rat model of acquired epilepsy.
Neurobiol Dis
; 194: 106469, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38485093
2.
Development of a novel immunoFET technology-based POC assay for detection of Leishmania donovani and Leishmania major.
Parasite Immunol
; 45(7): e12984, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37183939
3.
Understanding the immune responses involved in mediating protection or immunopathology during leishmaniasis.
Biochem Soc Trans
; 49(1): 297-311, 2021 02 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33449103
4.
Cutting Edge: CXCR3 Escapes X Chromosome Inactivation in T Cells during Infection: Potential Implications for Sex Differences in Immune Responses.
J Immunol
; 203(4): 789-794, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31253729
5.
MicroRNA-155 Deficiency Exacerbates Trypanosoma cruzi Infection.
Infect Immun
; 88(7)2020 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32312766
6.
STAT1 inhibits T-cell exhaustion and myeloid derived suppressor cell accumulation to promote antitumor immune responses in head and neck squamous cell carcinoma.
Int J Cancer
; 146(6): 1717-1729, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31709529
7.
Ibrutinib treatment inhibits breast cancer progression and metastasis by inducing conversion of myeloid-derived suppressor cells to dendritic cells.
Br J Cancer
; 122(7): 1005-1013, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32025027
8.
The Potent ITK/BTK Inhibitor Ibrutinib Is Effective for the Treatment of Experimental Visceral Leishmaniasis Caused by Leishmania donovani.
J Infect Dis
; 219(4): 599-608, 2019 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30239895
9.
MicroRNA 155 Contributes to Host Immunity against Leishmania donovani but Is Not Essential for Resolution of Infection.
Infect Immun
; 87(8)2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31182615
10.
From Birth to Weaning: A Window of Opportunity for Microbiota.
Nutrients
; 16(2)2024 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38257165
11.
Leishmania mexicana centrin knockout parasites promote M1-polarizing metabolic changes.
iScience
; 26(9): 107594, 2023 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37744404
12.
Leishmania major centrin knock-out parasites reprogram tryptophan metabolism to induce a pro-inflammatory response.
iScience
; 26(9): 107593, 2023 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37744403
13.
Leishmania mexicana promotes pain-reducing metabolomic reprogramming in cutaneous lesions.
iScience
; 26(12): 108502, 2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38125023
14.
The History of Live Attenuated Centrin Gene-Deleted Leishmania Vaccine Candidates.
Pathogens
; 11(4)2022 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35456106
15.
Centrin-deficient Leishmania mexicana confers protection against Old World visceral leishmaniasis.
NPJ Vaccines
; 7(1): 157, 2022 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36463228
16.
Centrin-deficient Leishmania mexicana confers protection against New World cutaneous leishmaniasis.
NPJ Vaccines
; 7(1): 32, 2022 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35236861
17.
Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL).
Front Cell Infect Microbiol
; 11: 685296, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34169006
18.
Revival of Leishmanization and Leishmanin.
Front Cell Infect Microbiol
; 11: 639801, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33816344
19.
Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development.
Front Immunol
; 12: 748325, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34712235
20.
From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection.
Expert Rev Vaccines
; 20(11): 1431-1446, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34511000